CB
Colossal BiosciencesColossal Biosciences is a genetic engineering company working to de-extinct species like the woolly mammoth and dire wolf while commercializing spinout biotech applications.
2 Pulse stories
EM
Encore MedicalEncore Medical develops transcatheter septal occlusion devices to repair structural heart defects like patent foramen ovale (PFO).
2 Pulse stories
Total Raised
$850M
Colossal BiosciencesEncore Medical
Last Valuation
$10.3B
Colossal BiosciencesEncore Medical
Biotech
Sector
Biotech
2021
Founded
2017
Dallas, Texas
HQ
Eagan, Minnesota
Private
Status
Public (EMI)
Colossal Biosciences investors
TWG GlobalThomas TullMark WalterTim DraperWinklevoss CapitalIn-Q-TelARCH Venture PartnersTom Brady
Encore Medical investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Colossal Biosciences and Encore Medical.